SPAA-52 |
| Katalog-Nr.GC69932 |
SPAA-52 ist ein niedermolekulares, oral wirksames, kompetitives und reversibles Inhibitor der Low-Molecular-Weight-Protein-Tyrosinphosphatase (LMW-PTP) mit einer Hemmkonzentration von 4 nM und einem Ki-Wert von 1,2 nM. SPAA-52 kann für die Erforschung von Diabetes eingesetzt werden.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for SPAA-52
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for SPAA-52
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *